R.PR
REGISTERED-PRINCIPAL REGISTER
04/09/2024
Back to search
Official data from USPTO
CARWIN PHARMACEUTICAL ASSOCIATES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CARWIN PHARMACEUTICAL ASSOCIATES
ST13
US500000097744366Class
5
Filing
97744366
Registration
7351111
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/10/2024
Trademark type
Word
Nice classes
5
Filing date
01/06/2023
Registration date
04/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/09/2024
Last transaction
04/10/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/01/2014
First use in commerce
06/01/2014
Drawing code
4
Owner type
16
Owner location
Hazlet, NJ
Examiner
EULIN, INGRID
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Carwin Pharmaceutical Associates, LLC
Representatives
Zoe Bernstein ZOE BERNSTEIN LAW PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vitamins; Allergy medication; Nutritional supplements; Pharmaceutical preparations for the treatment of pain associated with inflammationchronic inflammatory disease of musculoskeletal systempost-traumatic inflammation of soft tissue and musculoskeletal systempain in the spineneuralgiamyalgiaarthralgiapain and inflammation after surgery or injurypain in goutmigraine; Vitamin and mineral supplements; Prenatal vitamins
Publications
History of USPTO decisions and trademark events.
15 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/23/2024
PUBO
PUBLISHED FOR OPPOSITION
01/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/30/2023
GNRT
NON-FINAL ACTION E-MAILED
09/30/2023
CNRT
NON-FINAL ACTION WRITTEN
09/30/2023
DOCK
ASSIGNED TO EXAMINER
09/29/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/30/2023
NWAP
NEW APPLICATION ENTERED
01/10/2023
Continuous trademark protection
Get notified about every new filing that threatens CARWIN PHARMACEUTICAL ASSOCIATES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.